Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
48.79 USD
-0.41%
Market Closed
Updated:
Apr 24, 2024
Bristol-Myers Squibb Co
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
Bristol-Myers Squibb Co
Revenue Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Revenue
$8.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Bristol-Myers Squibb Co
Revenue Breakdown
Breakdown by Geography
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
|
Total Revenue:
45B
USD
|
|
United States:
31.6B
USD
|
|
International:
12.8B
USD
|
|
Other:
699m
USD
|
Breakdown by Segments
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
Not Available
See Also
What is Bristol-Myers Squibb Co's Revenue?
Revenue
45B
USD
45B
USD
Based on the financial report for Dec 31, 2023, Bristol-Myers Squibb Co's Revenue amounts to 45B USD.
What is Bristol-Myers Squibb Co's Revenue growth rate?
Revenue CAGR 10Y
11%
11%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Bristol-Myers Squibb Co have been 2% over the past three years , 15% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
